Communiqués IDEXX Laboratories, Inc.

Actions

IDXX

US45168D1046

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 20/06/2025			Varia. 5j.	Varia. 1 janv.
523,92 ^USD	+0,78%		+0,23%	+26,72%

20/06	IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10:55 AM
19/06	IDEXX Laboratories, Inc., Q1 2025 Earnings Call, May 01, 2025

Communiqués

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders	05/06	PR
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day	13/05	BU
Idexx: Q1 Earnings Snapshot	01/05	AQ
IDEXX Laboratories Announces First Quarter Results	01/05	BU
IDEXX Laboratories : Q1 2025 Earnings Snapshot	01/05	PU
IDEXX Laboratories to Release 2025 First Quarter Financial Results	03/04	BU
IDEXX Laboratories : Raymond James 46th Annual Institutional Investors Conference presentation	03/03	PU
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences	13/02	BU
Idexx: Q4 Earnings Snapshot	03/02	AQ
IDEXX Laboratories : Q4 2024 Earnings Snapshot	03/02	PU
IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results	03/02	BU
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results	16/01	BU
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX	19/12	AQ
IDEXX Laboratories : Announces Increase in Share Repurchase Program Authorization Form 8 K	09/12	PU
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization	09/12	BU
IDEXX Announces CFO Transition - IDEXX US	22/11	AQ
IDEXX Laboratories : Announces CFO Transition Form 8 K	21/11	PU
IDEXX Announces CFO Transition	21/11	BU
IDEXX Laboratories Announces Third Quarter Results	01/11	AQ
IDEXX Laboratories : Q3 2024 Earnings Snapshot	31/10/24	PU
IDEXX Laboratories : Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic Form 8 K	31/10/24	PU
Idexx: Q3 Earnings Snapshot	31/10/24	AQ
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results	31/10/24	BU
IDEXX Laboratories to Release 2024 Third Quarter Financial Results	30/09/24	BU
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference	21/08/24	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

Idexx Laboratories semble vouloir repartir sur une pente ascendante

Le 04 février 2025 à 15:22